In glioblastoma cells, AEG-1 acts as a glycolytic regulator, sensing the energy status of the cell, lowering the ATP/AMP ratio, and activating AMPK and its downstream targets, thereby maintaining sufficient amounts of ATP required for tumor proliferation and enhancing the glycolytic flux of the cell [62]. The gene discussed is MTDH; the disease is neoplasm.